semaglutide patent A Snapshot of the Landscape Ozempic's patent problem: how Novo

[PubMed: 40544433] Enebo LB, Berthelsen KK, Kankam M, et al

ClinicalTrials.gov lists active retatrutide studies that are recruiting participants

Drug Delivery Translational Research 9, 625630

[DOI] [PMC free article] [PubMed] [Google Scholar] 282.Das K, Rao LVM

Patients typically lose about 10 to 15% of their weight for every 3 months they take semaglutide, but results can vary

That interest could influence whether workers jump shipor stay on boardfor employers that cover GLP-1s for weight management: Cardiometabolic care tool 9amHealth found that more than two-thirds of the 1,300 Americans it surveyed would stay at a job they didnt like because of its GLP-1 coverage